1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

02 Dec 2025
Admin
News Article

mAIbe and LenioBio Join Forces to Accelerate Next-Gen Antibody Discovery

Two biotech innovators, mAIbe and LenioBio—have entered a strategic collaboration designed to push monoclonal antibody discovery into a faster, smarter, and more data-driven era.

This partnership blends AI-powered antibody design with cell-free protein expression, closing the loop between computational prediction and experimental validation.

Why This Collaboration Matters?

Antibody discovery often hits delays in early testing.
Slow expression systems and long build–test cycles create bottlenecks that limit iteration.

mAIbe and LenioBio aim to break that pattern.

Their integrated model brings together:

mAIbe’s AI-guided platform for antibody design and optimization
LenioBio’s ALiCE® cell-free expression technology, built for speed and scalability

The result: a tighter, faster design–build–test loop.

How the Partnership Works?

LenioBio’s system rapidly expresses even complex antibodies. This speed generates high-quality experimental data that flows directly into mAIbe’s AI models.

Together, the teams will:

Accelerate functional testing of AI-generated antibody candidates
Increase throughput in early-stage validation
Shorten iteration cycles between prediction and wet-lab data

This integrated workflow helps researchers validate more candidates in less time.

Setting a New Standard for Antibody R&D

The collaboration aims to close the long-standing gap between computational design and laboratory execution.

With:

Faster prototyping
Better experimental feedback
Higher precision in antibody optimization

mAIbe and LenioBio position themselves at the forefront of next-generation therapeutic antibody development.

About LenioBio

LenioBio GmbH develops cell-free protein expression solutions using its proprietary ALiCE® platform. The technology enables rapid discovery, development, and scalable production of complex proteins that are difficult to express in living cells.

About mAIbe

mAIbe specializes in AI-guided monoclonal antibody design. Its platform uses physics-informed generative AI and synthetic biology to engineer precise, cost-effective antibodies targeting viral and bacterial pathogens.

Let’s apply Data-Driven Pricing to Your APIs

Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.

Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.

Start using market intelligence today and allow yourself to be in control in the API market.

Check it out today and make more informed sourcing decisions! Learn More!